ImaginAb exercises an option to license exclusive worldwide rights to Oxford Biomedica 5T4 tumor antigen to engineer an in vivo diagnostic imaging agent

Oxford BioMedica plc

U.K. / Small-Cap Biopharma (<$1 billion)

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

ImaginAb Inc.

U.S. / Medical Devices and Diagnostics

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced